<i>TP53</i>-mutant AML with ribosomal gene loss exhibits impaired protein translation and sensitivity to HSP90 inhibition. [PDF]
Spinella JF +9 more
europepmc +1 more source
<i>Ganoderma lucidum</i> alcohol extract targets mutant <i>p53</i> signaling to inhibit proliferation in triple-negative breast brain metastasis cancer. [PDF]
Chien YC, Wu GW, Lin YH, Wu JY, Yu YL.
europepmc +1 more source
Kaempferol modulates the tryptophan metabolism pathway by increasing the abundances of Christensenellaceae R7 group, Bacteroides, and Blautia and reducing that of Rikenellaceae RC9 gut group, thereby significantly increasing the levels of ILA and IAA. This process inhibits the activation of NF‐κB/NLRP3 signaling pathway, reduces pro‐inflammatory factor
Xiangyu Liu +3 more
wiley +1 more source
Serositis as possible manifestation in MDS/AML patients with complex karyotype and TP53 mutation: case series. [PDF]
Gugole E +8 more
europepmc +1 more source
This review provides the first comprehensive synthesis focused exclusively on hypermucinous dysplasia, summarizing its histopathologic definition, precursor lesions, clinicopathological associations, molecular features, and diagnostic reproducibility.
Ádám Ferenczi +2 more
wiley +1 more source
TP53 codon 47 and 72 polymorphisms show no association with HPV in Zimbabwean women living with HIV and histologically confirmed cervical and vulvar disease. [PDF]
Kuguyo O +13 more
europepmc +1 more source
Summary of the Asia Pacific Advanced Prostate Cancer Symposium 2025, showing disciplines and diversity of participants, discussion topics (high‐risk localized/locally advanced prostate cancer; PSA persistence and recurrence; radioligand therapy; genetics and genomics; bone protection and other aspects of supportive care), key themes, and high‐level ...
Edmund Chiong +28 more
wiley +1 more source
Exploring the prognostic impact and biological functions of mutant-like TP53-related genes in acute myeloid leukemia. [PDF]
Bertoline LMF +4 more
europepmc +1 more source
A Spotlight on Yolk‐sac Tumors: Molecular Pathology, Current Diagnostics, and Novel Therapeutics
ABSTRACT Background Yolk‐sac tumors are an aggressive subtype of testicular cancer that significantly contribute to disease progression and therapy resistance, especially in adults. While testicular cancer generally has high cure rates with cisplatin‐based treatment, adult yolk‐sac tumors often appear as components of mixed tumors with poor response to
Evangelos Prokakis +3 more
wiley +1 more source

